2024    2023    2022    2021    2020    2019    2018    2017    2016   

2024

Articles

21 - 

Fatal natalizumab-associated progressive multifocal leukoencephalopathy with initial low JCV antibody index in a multiple sclerosis patient

M. Hay, S Leguy, V. Cahagne, N. Lassalle, Emmanuelle Le Page et al.

Revue Neurologique, 2024, Revue Neurologique,

DOI : https://doi.org/10.1016/j.neurol.2023.11.011

Pubmed : 38429158

 

22 - 

Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial

Nicholas Heming, Alain Renault, Emmanuelle Kuperminc, Christian Brun-Buisson, Bruno Megarbane et al.

The Lancet Respiratory Medicine, 2024,

DOI : https://doi.org/10.1016/S2213-2600(23)00430-7

Pubmed : 38310918

 

23 - 

Parkinsonian central pain is linked to the connectivity of the nucleus accumbens and the anterior insula

Karel Joineau, Mathilde Boussac, Patrice Peran, David Devos, Jean Luc Houeto et al.

Neuroimage: Reports, 2024, 4 (1), pp.100197.

DOI : https://doi.org/10.1016/j.ynirp.2024.100197

 

24 - 

High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

Guillaume Jouvenot, Guilhem Courbon, Mathilde Lefort, Fabien Rollot, Romain Casey et al.

JAMA neurology, 2024, pp.e240395.

DOI : https://doi.org/10.1001/jamaneurol.2024.0395

Pubmed : 38526462

 

25 - 

Nisin lantibiotic prevents NAFLD liver steatosis and mitochondrial oxidative stress following periodontal disease by abrogating oral, gut and liver dysbiosis

Ryutaro Kuraji, Changchang Ye, Chuanjiang Zhao, Li Gao, April Martinez et al.

npj Biofilms and Microbiomes, 2024, Npj Biofilms and Microbiomes, 10 (1), pp.3.

DOI : https://doi.org/10.1038/s41522-024-00476-x

Pubmed : 38233485

 

26 - 

Understanding the provenance and quality of methods is essential for responsible reuse of FAIR data

Tracey L. Weissgerber, Malgorzata Anna Gazda, Gustav Nilsonne, Gerben ter Riet, Kelly D Cobey et al.

Nature Medicine, 2024,

DOI : https://doi.org/10.1038/s41591-024-02879-x

Pubmed : 38514869

 

27 - 

How can the environmental sustainability of healthcare products be taken into account throughout their life cycle?

Bruno Laviolle, Pierre-Frédéric Degon, Cécile Gillet Giraud, Dominique Thiveaud, Philippe Lechat et al.

Therapies, 2024, 79 (1), pp.61-74.

DOI : https://doi.org/10.1016/j.therap.2023.12.001

Pubmed : 38102030

 

28 - 

Two human milk–like synthetic bacterial communities displayed contrasted impacts on barrier and immune responses in an intestinal quadricellular model

Charles Le Bras, Lucie Rault, Nolwenn Jacquet, Nathalie Daniel, Victoria Chuat et al.

ISME Communications, 2024, 4 (1), pp.ycad019.

DOI : https://doi.org/10.1093/ismeco/ycad019

Pubmed : 38415201

 

29 - 

Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1 infected-patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER Study)

Florian Lemaitre, Jennifer Lagoutte-Renosi, Marie-Claude Gagnieu, François Parant, Nicolas Venisse et al.

British Journal of Clinical Pharmacology, 2024, 90 (1), pp.264-273.

DOI : https://doi.org/10.1111/bcp.15890

Pubmed : 37602480

 

30 - 

Impact of multiple sclerosis on employment and income: Insights from a random sample representative of private sector employees in France using longitudinal administrative data

E. Leray, C. Regaert, E. Duguet, S. Guillaume, S. Pichetti et al.

Revue Neurologique, 2024,

DOI : https://doi.org/10.1016/j.neurol.2024.02.389

Pubmed : 38582662